Glutathione: Antioxidant Function, Detoxification, Supplement Methods and Research

Glutathione is frequently described as the body’s “master antioxidant.”

While that phrase captures its importance, it can also oversimplify a complex biological system. Glutathione does not work alone, nor does increasing glutathione automatically cleanse the body, prevent disease or reverse ageing.

Glutathione is a naturally produced molecule found in virtually every human cell. It helps regulate oxidative balance, supports the metabolism of certain compounds and participates in immune function, cellular signalling and protein maintenance.

Interest in glutathione has led to multiple administration methods, including:

• Standard oral glutathione capsules
• Liposomal glutathione
• Sublingual and buccal formulations
• N-acetylcysteine and other glutathione precursors
• Intravenous glutathione
• Experimental injectable and subcutaneous glutathione

These methods are not equally supported by clinical evidence and should not be treated as interchangeable.

This guide explains what glutathione is, how it works, what reduced and oxidised glutathione mean, how the body produces glutathione and what research shows about oral, liposomal and injectable administration.

What is glutathione?

Glutathione is a naturally occurring tripeptide composed of three amino acids:

1. Glutamate
2. Cysteine
3. Glycine

A tripeptide is a short molecule formed from three amino-acid components.

Glutathione is often abbreviated to GSH, particularly when referring to its reduced form.

Unlike many proteins, glutathione is not produced directly from a single genetic template. Cells manufacture it through two enzyme-controlled stages using the amino acids already available within the cell.

The liver contains high concentrations of glutathione because it is a major centre for metabolism and the processing of foreign compounds. Glutathione is also important in the lungs, kidneys, brain, immune cells and skeletal muscle.

What does glutathione do?

Glutathione performs several interconnected biological functions.

These include:

• Maintaining cellular redox balance
• Supporting glutathione peroxidase enzymes
• Participating in the metabolism of reactive compounds
• Supporting liver conjugation pathways
• Helping regenerate other antioxidants
• Protecting protein thiol groups
• Influencing immune-cell function
• Supporting mitochondrial integrity
• Participating in cellular signalling
• Assisting the breakdown and removal of certain substances

Glutathione is sometimes described as an antioxidant that simply neutralises free radicals. Its biology is more sophisticated.

Reactive oxygen species are not universally harmful. At controlled levels, they participate in immune defence and normal cellular signalling.

Glutathione helps regulate this environment rather than attempting to eliminate every oxidising molecule.

Reduced glutathione vs oxidised glutathione

Glutathione exists in several forms, but two are particularly important:

• Reduced glutathione—GSH
• Oxidised glutathione—GSSG

Reduced glutathione can donate electrons during antioxidant reactions. When two glutathione molecules become oxidised, they can join to form glutathione disulphide, or GSSG.

The enzyme glutathione reductase can convert GSSG back into GSH using reducing power supplied by NADPH.

This creates a continuous recycling system:

1. GSH participates in a reaction
2. GSH becomes oxidised
3. Oxidised glutathione forms GSSG
4. Glutathione reductase converts GSSG back into GSH

The ratio between reduced and oxidised glutathione is sometimes used as an indicator of cellular redox status.

A higher GSH-to-GSSG ratio is generally associated with a more reducing cellular environment. A shift towards GSSG may occur during oxidative stress.

However, blood measurements do not necessarily represent glutathione status inside every tissue.

How does the body produce glutathione?

Glutathione synthesis occurs in two ATP-dependent stages.

Stage one: gamma-glutamylcysteine production

Glutamate and cysteine are combined by an enzyme known as glutamate-cysteine ligase.

This is generally considered the rate-limiting stage of glutathione synthesis.

Cysteine availability can be particularly important because intracellular cysteine is often more limited than glutamate or glycine.

Stage two: glutathione production

Glycine is added by glutathione synthetase, producing glutathione.

The resulting GSH can be used in antioxidant, metabolic and signalling reactions.

Cells can also recycle components of extracellular glutathione through the gamma-glutamyl cycle.

Glutathione and oxidative stress

Oxidative stress occurs when the production of reactive species exceeds the capacity of cellular defence and repair systems.

Reactive oxygen species can arise from:

• Normal mitochondrial metabolism
• Immune responses
• Environmental pollutants
• Tobacco smoke
• Radiation
• Inflammation
• Certain medicines
• Metabolism of foreign compounds

Glutathione peroxidase enzymes use GSH to help reduce hydrogen peroxide and lipid hydroperoxides.

Through these reactions, glutathione helps limit damage to:

• Cell membranes
• Proteins
• Mitochondrial components
• DNA
• Cellular enzymes

Glutathione is only one part of the antioxidant network. Other participants include catalase, superoxide dismutases, thioredoxin systems, vitamin C, vitamin E and numerous repair enzymes.

More antioxidant activity is not automatically better. Reactive species also carry useful biological signals, so redox balance is more important than eliminating oxidation completely.

Glutathione and liver detoxification

Glutathione is strongly associated with liver detoxification, but the word “detox” is frequently misused.

The liver does not simply collect undefined “toxins” and flush them out. It uses multiple enzyme systems to chemically transform substances so they can be processed or eliminated.

Glutathione is particularly important in certain phase II conjugation reactions.

Glutathione S-transferase enzymes can attach glutathione to reactive or electrophilic compounds. This may make them less reactive and support further metabolism and excretion.

Glutathione also participates in the metabolism of some:

• Environmental chemicals
• Drug metabolites
• Products of oxidative stress
• Endogenous reactive compounds

One medically important example involves paracetamol overdose. A reactive paracetamol metabolite can deplete liver glutathione and cause severe liver injury.

N-acetylcysteine is used medically because it helps replenish cysteine and supports glutathione synthesis. This is a specific, evidence-based medical application—not proof that general glutathione supplementation removes every toxin.

Glutathione and mitochondrial function

Mitochondria generate reactive oxygen species as part of normal energy metabolism.

Mitochondrial glutathione helps regulate this environment and supports the protection of mitochondrial proteins, membranes and DNA.

Mitochondria do not efficiently synthesise glutathione from its three amino acids. They rely substantially on glutathione produced elsewhere in the cell and transported into the mitochondrial compartment.

Mitochondrial glutathione has been studied in relation to:

• Respiratory-chain function
• Lipid oxidation
• Cellular stress
• Apoptosis
• Inflammation
• Neurodegeneration
• Liver injury
• Metabolic disease

A change in blood glutathione does not prove that mitochondrial glutathione has increased in a particular organ.

This compartmentalisation is an important limitation when interpreting supplement studies.

Glutathione and immune function

Immune cells generate reactive species to help respond to pathogens.

They also require antioxidant systems to protect themselves from the reactive environment they create.

Glutathione is involved in:

• Lymphocyte activity
• Cytokine signalling
• Antigen processing
• Immune-cell proliferation
• Redox-sensitive gene regulation
• Protection from excessive oxidative damage

Low glutathione levels have been observed in several illnesses, but this does not automatically mean low glutathione caused the condition or that supplementation will treat it.

Illness itself can increase oxidative stress and glutathione consumption.

Does glutathione decline with age?

Changes in glutathione status have been associated with ageing, chronic disease, diet and environmental exposure.

Possible contributors include:

• Reduced synthesis
• Lower cysteine or glycine availability
• Increased oxidative stress
• Chronic inflammation
• Reduced recycling capacity
• Mitochondrial dysfunction
• Medication use
• Poor nutritional status

Human results vary by tissue, health status and measurement technique.

It is therefore more accurate to say that glutathione metabolism may become less resilient with age in some people and tissues, rather than claiming everyone develops a universal glutathione deficiency.

Methods of increasing glutathione

Glutathione can be approached in two broad ways:

1. Administering glutathione itself
2. Providing substrates or precursors the body uses to produce glutathione

Commonly discussed methods include:

• Oral reduced glutathione
• Liposomal glutathione
• Sublingual glutathione
• Intravenous glutathione
• Experimental SubQ glutathione
• N-acetylcysteine
• Glycine and cysteine combinations
• Dietary protein and sulphur-containing foods

Each method presents different questions of absorption, metabolism, safety and evidence.

Method 1: Standard oral glutathione capsules

How does oral glutathione work?

Standard oral glutathione passes through the gastrointestinal system.

The peptide may be:

• Broken down by digestive enzymes
• Metabolised at the intestinal surface
• Absorbed partly intact
• Separated into constituent amino acids
• Used locally within the intestinal environment

For many years, oral glutathione was assumed to have poor bioavailability because it is a peptide exposed to digestion.

Human research has produced mixed results.

What does oral glutathione research show?

A 2011 randomised controlled study involving 40 healthy adults found no significant change in glutathione status or oxidative-stress biomarkers after four weeks of oral supplementation.

A larger 2015 randomised controlled study reported that six months of oral glutathione increased glutathione levels in several body compartments.

These different findings may reflect:

• Study duration
• Participant characteristics
• Formulation
• Baseline glutathione status
• Laboratory methods
• Tissue measured
• Adherence
• Biological variability

The evidence suggests some oral formulations can influence glutathione status, but results are not universal.

Research use cases for oral glutathione

Oral glutathione may be studied when researchers want to:

• Examine longer-term supplementation
• Avoid invasive administration
• Measure changes in blood-cell glutathione
• Investigate oxidative-stress biomarkers
• Compare direct glutathione with precursor strategies
• Conduct placebo-controlled trials

It has not been proven to treat every condition associated with oxidative stress.

Advantages of oral glutathione

• Non-invasive
• Convenient
• Lower procedural risk
• Suitable for longer-duration studies
• Can be compared with placebo
• Some controlled human evidence

Limitations of oral glutathione

• Variable absorption
• Digestive breakdown
• Differences between formulations
• Blood changes may not reflect tissue effects
• Mixed human findings
• Limited evidence for broad clinical benefits

Method 2: Liposomal glutathione

What is liposomal glutathione?

Liposomal glutathione encloses glutathione within small lipid-based structures called liposomes.

The proposed purpose is to protect glutathione from degradation and improve delivery across biological membranes.

A liposome consists of phospholipid layers similar to those found in cell membranes.

Product design matters. Two products described as liposomal may differ in:

• Liposome size
• Lipid composition
• Stability
• Encapsulation efficiency
• Manufacturing quality
• Storage requirements
• Release characteristics

The word “liposomal” alone does not prove superior absorption.

What does liposomal glutathione research show?

A small one-month pilot study in healthy adults reported increases in glutathione levels in blood and certain immune cells after liposomal glutathione supplementation.

Other research has examined liposomal formulations in people with type 2 diabetes and inflammatory conditions.

More recent formulation studies suggest certain liposomal or micellar systems can produce greater systemic exposure than standard glutathione preparations.

However:

• Many studies are small
• Some lack a placebo group
• Formulations differ
• Biomarker changes do not prove clinical benefit
• Findings may not apply across products

Research use cases for liposomal glutathione

A liposomal preparation may be studied when the objective is to:

• Improve oral stability
• Compare systemic exposure
• Investigate formulation-dependent absorption
• Avoid injectable administration
• Examine whether higher bioavailability changes biomarkers

It should not automatically be described as clinically superior without evidence for the exact formulation.

Method 3: Glutathione precursors

Instead of supplying glutathione directly, researchers may provide the amino acids required for glutathione synthesis.

N-acetylcysteine

N-acetylcysteine, or NAC, is a cysteine precursor with established medical uses.

Cysteine is often the limiting substrate in glutathione production. Providing NAC can increase cysteine availability and support endogenous glutathione synthesis.

NAC has recognised clinical roles, including treatment of paracetamol overdose and use as a mucolytic medicine.

This does not mean routine NAC supplementation is necessary or beneficial for everyone.

Glycine

Glycine is another component of glutathione.

Some research suggests glycine availability may limit glutathione synthesis in certain older or metabolically unwell populations.

GlyNAC

GlyNAC combines glycine and N-acetylcysteine to provide two of glutathione’s three amino-acid components.

Small human studies have explored GlyNAC in relation to:

• Glutathione synthesis
• Oxidative stress
• Mitochondrial function
• Insulin sensitivity
• Physical function
• Age-associated metabolic changes

Larger independent trials are needed before broad anti-ageing claims can be supported.

Research use cases for precursor supplementation

A precursor strategy may be selected when researchers want to:

• Support the body’s regulated synthesis pathway
• Investigate substrate limitations
• Avoid administering intact glutathione
• Examine longer-term metabolic effects
• Compare direct and indirect glutathione strategies

Method 4: Intravenous glutathione

What is IV glutathione?

Intravenous glutathione delivers a glutathione-containing solution directly into a vein.

This bypasses gastrointestinal digestion and creates direct exposure within the bloodstream.

However, IV delivery does not guarantee that intact glutathione will enter every cell or reach mitochondrial compartments.

Extracellular glutathione may be:

• Broken down at cell surfaces
• Processed through the gamma-glutamyl cycle
• Used in extracellular redox reactions
• Cleared from circulation
• Converted into component amino acids

Why is IV glutathione studied?

Legitimate research may investigate IV glutathione when researchers need:

• Controlled systemic administration
• Defined exposure timing
• Clinical supervision
• Frequent blood sampling
• Condition-specific outcome measurements
• Pharmacokinetic information

IV glutathione has been studied in several medical contexts, but the evidence is condition-specific and cannot be generalised to wellness, anti-ageing or cosmetic use.

Common commercial IV glutathione claims

Commercial clinics may promote IV glutathione for:

• Detoxification
• Energy
• Immune support
• Anti-ageing
• Recovery
• Skin lightening
• General wellness

Large, high-quality clinical trials do not establish these broad claims.

Risks of IV glutathione

Intravenous administration introduces risks beyond the biological effects of glutathione itself:

• Infection
• Vein irritation
• Allergic or infusion reactions
• Incorrect concentration
• Particulate contamination
• Microbial contamination
• Endotoxin exposure
• Errors in preparation
• Inappropriate formulation
• Lack of emergency supervision

Current FDA injectable-glutathione warning

On 27 August 2026, the FDA warned compounders not to use dietary-supplement-grade glutathione to manufacture injectable products.

The warning followed reports of adverse events including:

• Fever
• Chills
• Pain
• Dizziness
• Shock-like symptoms
• Sepsis-like reactions
• Hospitalisations

The FDA stated that these reactions were consistent with excessive endotoxin exposure.

In August 2026, multiple lots of compounded glutathione injections were also recalled after elevated bacterial-endotoxin levels were identified.

Reported reactions included:

• Severe headaches
• Nausea and vomiting
• Changes in blood pressure
• Rapid heart rate
• Body aches
• Injection-site reactions
• Allergic-type reactions

Endotoxin exposure from an injectable product can potentially cause hypotension, inflammatory reactions, shock and death.

These warnings demonstrate why chemical purity alone is insufficient for an injectable preparation.

Method 5: Subcutaneous glutathione

What is SubQ glutathione?

Subcutaneous, or SubQ, glutathione refers to glutathione administered into the tissue beneath the skin.

This route is sometimes promoted as more convenient than an IV infusion.

However, there is no robust body of human evidence establishing:

• SubQ glutathione bioavailability
• Human pharmacokinetics
• Validated clinical indications
• Long-term safety
• Superiority to oral formulations
• A standard self-administration protocol
• General anti-ageing or detoxification benefits

Theoretical differences from IV glutathione

Subcutaneous administration may generally produce slower absorption than direct intravenous delivery.

Specific human data are required before this can be confidently applied to glutathione.

Important unanswered questions include:

• How much remains intact
• How much is broken down locally
• Whether absorption is predictable
• How local tissue responds
• Whether systemic exposure is meaningful
• Whether repeated exposure causes irritation

Potential SubQ glutathione risks

• Injection-site pain
• Redness
• Swelling
• Bruising
• Tissue inflammation
• Infection
• Abscess formation
• Unpredictable absorption
• Endotoxin exposure
• Contamination
• Incorrect pH or concentration

SubQ glutathione remains an experimental route rather than an established general treatment.

Oral vs liposomal vs IV vs SubQ glutathione

Method	Evidence level	Main research purpose	Principal limitation
Standard oral glutathione	Developing	Longer-term supplementation	Variable absorption
Liposomal glutathione	Early/developing	Formulation and bioavailability	Small formulation-specific studies
NAC or precursors	Moderate and condition-specific	Supporting endogenous synthesis	Not equivalent to direct glutathione
IV glutathione	Limited and condition-specific	Controlled clinical exposure	Invasive, sterility and endotoxin risks
SubQ glutathione	Very limited	Experimental route research	Pharmacokinetics and efficacy unestablished

Glutathione and skin lightening

Glutathione has been promoted as a skin-lightening or skin-brightening compound.

Proposed mechanisms include:

• Interference with tyrosinase activity
• Changes in melanin production
• A shift from darker eumelanin towards lighter pheomelanin
• Antioxidant effects within skin cells

Small studies have reported modest changes in skin-colour measurements with certain oral or topical formulations.

However:

• Studies are generally small
• Results vary by body area
• Effects may not be permanent
• Long-term safety is unclear
• Formulations differ
• Evidence quality is limited

Injectable glutathione should not be considered a validated cosmetic treatment. The potential for severe reactions and product-quality failures is disproportionate to an unproven cosmetic benefit.

Glutathione and “detox” claims

Glutathione participates in specific liver-conjugation and redox pathways.

That does not support claims that supplementation will:

• Remove undefined toxins
• Reverse an unhealthy diet
• Eliminate alcohol-related harm
• Cure chronic fatigue
• Cleanse every organ
• Replace medical treatment
• Prevent all oxidative damage

A scientifically accurate statement is:

Glutathione participates in the metabolism and processing of certain reactive compounds.

A misleading statement would be:

Glutathione flushes all toxins from the body.

Glutathione and ageing

Ageing is associated with changes in redox regulation, mitochondrial function, inflammation and cellular repair.

Glutathione is relevant to these systems, which makes it an important subject of healthy-ageing research.

Preclinical and early human studies have investigated whether supporting glutathione synthesis could affect:

• Oxidative-stress markers
• Mitochondrial function
• Insulin sensitivity
• Muscle function
• Inflammation
• Physical performance

There is currently no convincing evidence that glutathione supplementation:

• Reverses biological ageing
• Extends human lifespan
• Prevents all age-related disease
• Produces universal longevity benefits

Glutathione and cancer: an important distinction

Glutathione helps protect healthy cells from oxidative and chemical stress.

Cancer cells can also use glutathione systems to survive oxidative stress and resist certain treatments.

Higher glutathione activity within some tumours may contribute to resistance against chemotherapy.

This does not mean glutathione causes cancer. It demonstrates that antioxidant biology depends on cellular context.

People undergoing cancer treatment should not use glutathione, NAC or high-dose antioxidant products without discussing them with their oncology team.

Frequently asked questions

What is glutathione?

Glutathione is a three-amino-acid molecule composed of glutamate, cysteine and glycine. It participates in antioxidant defence, redox signalling and the metabolism of reactive compounds.

What does GSH mean?

GSH usually refers to reduced glutathione—the electron-donating form involved in many antioxidant reactions.

What does GSSG mean?

GSSG is glutathione disulphide, commonly called oxidised glutathione. Glutathione reductase can convert it back into GSH.

Is glutathione a peptide?

Yes. Glutathione is a tripeptide formed from three amino acids.

Does oral glutathione work?

Some human studies report increased glutathione levels after longer-term oral supplementation, while others report no significant changes. Results may depend on formulation, duration and the tissue measured.

Is liposomal glutathione better?

Certain liposomal formulations may improve systemic exposure, but findings are product-specific. Evidence that improved absorption consistently produces better health outcomes remains limited.

Is NAC the same as glutathione?

No. NAC supplies cysteine, which the body can use to produce glutathione. It is a precursor rather than glutathione itself.

What is IV glutathione used for?

IV glutathione has been investigated in specific clinical research settings. It is also promoted commercially for wellness and skin lightening, but these broad applications lack strong clinical evidence.

Is injectable glutathione safe?

Injectable administration carries risks involving sterility, endotoxins, preparation errors and acute reactions. Recent FDA warnings and recalls have involved serious reactions from contaminated compounded glutathione products.

Can glutathione be administered SubQ?

SubQ administration is discussed commercially, but robust human pharmacokinetic, efficacy and long-term safety evidence is lacking.

Does glutathione lighten skin?

Small studies suggest certain oral or topical formulations may cause modest changes in some skin-colour measurements. Injectable glutathione is not a proven safe cosmetic treatment.

Does glutathione detox the liver?

Glutathione participates in specific liver metabolic pathways. It should not be described as a universal liver cleanse or a method for removing undefined toxins.

Does glutathione help with ageing?

Glutathione is involved in biological pathways relevant to ageing, but supplementation has not been proven to reverse ageing or extend human lifespan.

Can glutathione be combined with NAD+?

The molecules participate in interconnected redox systems, but there is no established evidence that combining commercial NAD+ and glutathione products creates a clinically proven anti-ageing or “detox” treatment.

Glutathione vs NAD+

Glutathione and NAD+ are different molecules with interconnected roles.

Feature	Glutathione	NAD+
Molecule type	Tripeptide	Dinucleotide coenzyme
Principal role	Redox buffering and conjugation	Electron transfer and enzyme activity
Reduced form	GSH	NADH
Oxidised form	GSSG	NAD+
Synthesis	Glutamate, cysteine and glycine	Tryptophan and vitamin B3-related pathways
Proven anti-ageing effect	No	No

Glutathione recycling relies partly on NADPH, while NAD+ and NADH are central to energy metabolism.

Both contribute to cellular redox biology, but neither should be marketed as a universal standalone solution. For a detailed look at NAD+ itself—its role in mitochondria, sirtuins and ageing—see our guide to NAD+, mitochondrial function and ageing.

NŪVO Research Perspective

Glutathione is one of the most important components of human redox biology.

Its scientific value comes from established roles in:

• Peroxide metabolism
• Protein protection
• Cellular signalling
• Conjugation reactions
• Immune-cell function
• Mitochondrial maintenance

The uncertainty concerns whether a specific method of administration produces a meaningful clinical benefit.

Oral and liposomal glutathione have a developing evidence base. Precursor strategies support the body’s own synthesis pathways. IV glutathione has limited, condition-specific research and introduces serious manufacturing and administration risks. SubQ glutathione remains experimental.

The most scientifically responsible approach is to distinguish essential biological function from claims made about a commercial formulation. Browse the research catalogue — every compound is supplied for laboratory research only.

Research and medical disclaimer

This article is provided for educational and scientific-information purposes only. It does not constitute medical advice, dosing guidance, injection instructions or a recommendation to administer glutathione.

Research-grade products are not medicines and must not be used for human administration. HPLC purity does not demonstrate sterility, endotoxin control, stability, correct concentration or injectable suitability.

Anyone considering a supplement or medically supervised treatment should consult an appropriately qualified healthcare professional.

Sources and further reading

1. Dickinson DA and Forman HJ. Glutathione in defence and signalling: lessons from a small thiol. Annals of the New York Academy of Sciences, 2002. View the research on PubMed
2. Exner R, et al. Therapeutic potential of glutathione. Wiener Klinische Wochenschrift, 2000. View the review on PubMed
3. Richie JP Jr, et al. Randomised controlled trial of oral glutathione supplementation. European Journal of Nutrition, 2015. View the clinical trial on PubMed
4. Allen J and Bradley RD. Effects of oral glutathione supplementation on systemic oxidative-stress biomarkers. 2011. View the randomised trial on PubMed
5. Sinha R, et al. Oral liposomal glutathione elevates body stores of glutathione and markers of immune function. European Journal of Clinical Nutrition, 2018. View the pilot study on PubMed
6. Dilokthornsakul W, et al. Clinical effects of glutathione on skin colour: a systematic review. 2019. View the systematic review on PubMed
7. Rushworth GF and Megson IL. Existing and potential therapeutic uses for N-acetylcysteine. Clinical Science, 2014. View the review on PubMed
8. Desideri E, et al. Targeting glutathione metabolism in cancer. Cell Death & Disease, 2019. View the review on PubMed
9. US Food and Drug Administration. FDA reminds compounders not to use dietary-supplement-grade glutathione in injectable drugs. 27 August 2026. Read the current FDA safety warning
10. US Food and Drug Administration. Concerns about using dietary-ingredient glutathione in sterile compounded injectables. Read the FDA investigation
11. US Food and Drug Administration. Recall of compounded glutathione injection due to elevated endotoxin levels. August 2026. Read the FDA recall notice